1,000+ M&A transactions for an aggregate value of $465+ billion since 2019
Cooley Continues Upward Momentum in Global M&A Rankings
Learn More
Cooley Stands Apart in Women and M&A Deal Leadership
Learn More
Cooley Shortlisted Across 15 Categories in The Deal’s Annual Awards
Learn More
Amazon to Acquire One Medical for $3.9 Billion
Learn More
Turning Point Therapeutics to Sell to Bristol Myers Squibb for $4.1 Billion
Learn More
Grindr Agrees to Merge With SPAC Tiga Acquisition Corp.
Learn More
Cornerstone OnDemand Agrees to Sell to Clearlake Capital Group for $5.2 Billion
Learn More
Vividion Therapeutics Agrees to Sell to Bayer for up to $2 Billion
Learn More
Japan’s Paidy Agrees to Sell to PayPal for $2.7 Billion
Learn More
Why Cooley
- 180+ member team in 17 major business and technology centers in the US, Europe and Asia
- Broad industry platform with clients across many industries and sophisticated capabilities in all practice areas
- Excel in deals in the tech, life sciences, medical device and healthcare, consumer, education, defense and media industries
- Given our market position in the medtech and life sciences sectors, we have handled a large number of life sciences M&A transactions, both public and private, and understand unique structuring issues for life sciences companies, including milestone structures, contingent value rights and option structures
- Primary corporate counsel to 240+ public companies, giving us an unmatched perspective on market deal points and ability to facilitate introductions between buyers and sellers
- Represent all categories of participants in transactions, including buyers, sellers, major stockholders, venture capitalists, lenders, financial advisors, management/founders, special board committees, individual investors, private equity funds, hedge funds and others
- Adept at handling all manner of transactions, including domestic and cross-border mergers and acquisitions, strategic deals including joint ventures, acquisitions of IP assets, patent cross-licenses, complex divestitures and spin-offs, takeover defense and shareholder activism counseling, and multibillion-dollar public company mergers
- Robust SPAC experience and thought leaders in the area with a repository of market insight and guidance for businesses interested in the IPO alternative @ SPACtivity
- Market-leading IP, privacy, technology licensing, life sciences collaborations and licensing, regulatory, government contracts, credit finance, private equity, antitrust, employment, compensation and tax practices to support transactions
Public Company Innovation Hub
Resources for forward-thinking board members and leaders of US-listed public companies
Visit hub
Recognition
-
Chambers: Band 2 for USA - Nationwide Corporate/M&A (2022)
-
Mergermarket: Top 3 for US M&A by Deal Count (2022 H1)
-
Bloomberg: Top 4 for Global M&A by Deal Count (2022 H1)
-
Mergermarket: Top 4 for US M&A Exits by Deal Count (2021)
-
Mergermarket: Top 5 for Global M&A Exits by Deal Count (2021)
-
Bloomberg: #2 for US Mid-market M&A (2021)
-
Bloomberg: Top 3 for US Mid-market M&A by count (2021)
-
Bloomberg: #2 for Global Private Equity (2021)
-
Bloomberg: Top 3 for Global Private Equity by count (2021)
-
The Deal: Top 10 M&A Law Firms Power Rankings by count (2021)
-
Pitchbook: #5 Most Active Firm Globally Representing Companies (2021)
-
Pitchbook: #3 Most Active Firm in the US Representing Companies (2021)
M&A Blog
Newsworthy developments in the global mergers and acquisitions space
View blog
Group contacts
Anne Lieberman
Partner
Los Angeles – Santa Monica, Los Angeles – Downtown
ViewHide related contacts
+-
Listing Returned 0 Results.
-
{{ item.name }}
{{ item.title }}
{{ item.location }}{{ item.secondaryoffices}}
-
{{ item.name }}
{{ item.title }}
{{ item.location }}{{ item.secondaryoffices}}
ViewHide related news
+-
Listing Returned 0 Results.
ViewHide related events
+-
Listing Returned 0 Results.